Eli Lilly Stock Would Win Big If Weight-Loss Drug Market Hits $100 Billion
Eli Lilly and Denmark's Novo Nordisk are expected to roughly split the market for weight-loss drugs, both as diabetes and obesity treatments.
Source: marketwatch.com
Stay updated with breaking news from Daniel Acker Bloomberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly and Denmark's Novo Nordisk are expected to roughly split the market for weight-loss drugs, both as diabetes and obesity treatments.
Even a small shift in mortgage rates could make a big difference to home affordability.
Even a small shift in mortgage rates could make a big difference to home affordability.
J&J plans to maintain its quarterly dividend even after separating its Kenvue business. It didn't have to do that to keep its status as a Dividend Aristocrat.
Even a small shift in mortgage rates could make a big difference to home affordability.